Navigation Links
Zimmer Acquires Knee Creations, LLC's Business

WARSAW, Ind., May 2, 2013 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH) announced today that it has acquired the business assets of West Chester, Pennsylvania-based Knee Creations, LLC. The acquisition enhances Zimmer's product portfolio of knee treatments through the addition of Knee Creations' Subchondroplasty® procedure. Subchondroplasty is an innovative, proprietary joint-preservation treatment that has been shown to deliver sustained relief to patients with knee pain, with or without arthritis. It is the first procedure to address an unmet clinical need between early interventions, including NSAIDs and arthroscopy, and total joint replacement.

"Zimmer is committed to developing the most comprehensive range of therapies for knee patients, from early intervention and joint preservation products to patient specific instrumentation and personalized joint replacements," said Jeff McCaulley, President, Zimmer Reconstructive. "The acquisition of Knee Creations' revolutionary Subchondroplasty treatment provides Zimmer with another clinically differentiated offering that addresses an unmet clinical need."

Marc R. Viscogliosi , a founder and Chairman of the Board of Managers of Knee Creations, LLC, stated, "On behalf of the Knee Creations board and its whole investor base, we are pleased that Zimmer will be the new owner of this business and technology, enabling it to further flourish for the benefit of patients and physicians. As a global leader, we believe Zimmer can make the greatest impact with the revolutionary Subchondroplasty procedure platform."  

Subchondroplasty is a percutaneous outpatient intervention that addresses the defects associated with subchondral bone marrow edema (BME). BMEs are related to stress fractures or micro-fractures and are diagnosed using MRI. Left untreated, these defects have been shown to lead to cartilage degeneration, limited function, pain and greater risk for joint deterioration.     

In this minimally invasive, arthroscopically-assisted procedure, navigation instruments are used to inject a specialized bone void filler to treat the bone defect and begin the healing process, without violating the joint. Since its introduction in November 2010, more than 1,500 Subchondroplasty procedures have been completed.

Viscogliosi & Company, LLC (V&CO) acted as exclusive financial advisor to Knee Creations. V&CO is a FINRA registered brokerage dealer, investment bank and advisory firm that represents buyers, sellers and owners of surgeon driven, patient-focused innovative products and technologies.

About Zimmer Holdings, Inc.
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2012 sales were approximately $4.5 billion. The Company is supported by the efforts of more than 8,500 employees worldwide.

About Knee Creations, LLC
Founded by Viscogliosi Brothers, LLC in 2007, and based in West Chester, Pennsylvania, Knee Creations, LLC operates as a provider of unique knee treatments. The Company is focused on integrating cutting-edge scientific research into first-of-a-kind surgical solutions to treat defects associated with subchondral bone marrow edema (BME). The company was funded with an angel equity round and a Series A equity round of financing, together with debt, led by Viscogliosi Brothers, LLC, Praefinium and Philadelphia Medical Investment Group, LLC.   

Zimmer Safe Harbor Statement
This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management.  Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially. For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.

SOURCE Zimmer Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Zimmer Holdings, Inc. Reports First Quarter 2013 Financial Results
2. Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2013 Results
3. Zimmer Launches Single Injection Pain Relief Solution at the 2013 AAOS Annual Meeting
4. UPDATE: Zimmer Announces 11% Increase in Quarterly Dividend for First Quarter of 2013
5. Zimmer Announces 11% Increase in Quarterly Dividend for First Quarter of 2013
6. Zimmer Holdings to Present at Canaccord Genuitys Musculoskeletal Conference
7. Zimmer Holdings to Present at Barclays Capital 2013 Global Healthcare Conference
8. Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.
9. Zimmer Reports Fourth Quarter and 2012 Financial Results
10. Zimmer Receives FDA Clearance for Revolutionary New Surgical Guidance Technology
11. Amarantus BioSciences Appoints Dr. Robert J. Zimmerman as Product Development Advisor
Post Your Comments:
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American ... function testing company, is now able to perform sophisticated lung assessments ... ndd Medical Technologies , Inc. Patients are no ...  Thanks to ndd,s EasyOne PRO ® , ARL patients like Jeanne ... needed testing done in the comfort of her own home. ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... recently awarded their highest five-star ... , Millions of individuals in the United States and Canada wear eyeglasses. Once considered ... both correct vision and make a fashion statement. Even celebrities use glasses as a ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
Breaking Medicine News(10 mins):